Primary |
Contraception |
28.5% |
Acne |
11.4% |
Product Used For Unknown Indication |
11.1% |
Premenstrual Syndrome |
10.3% |
Oral Contraception |
6.7% |
Pain |
5.1% |
Depression |
4.1% |
Asthma |
3.0% |
Menstruation Irregular |
2.2% |
Menstrual Cycle Management |
2.0% |
Anxiety |
1.9% |
Hypertension |
1.8% |
Migraine |
1.8% |
Drug Use For Unknown Indication |
1.6% |
Headache |
1.6% |
Multiple Allergies |
1.6% |
Polycystic Ovaries |
1.6% |
Gastrooesophageal Reflux Disease |
1.5% |
Nausea |
1.2% |
Menorrhagia |
1.2% |
|
Pain |
16.9% |
Injury |
13.9% |
Deep Vein Thrombosis |
10.3% |
Pulmonary Embolism |
10.0% |
Emotional Distress |
6.3% |
Gallbladder Disorder |
5.8% |
Anxiety |
5.2% |
Cholecystitis Chronic |
4.5% |
Cholelithiasis |
4.4% |
Cholecystectomy |
3.2% |
Metrorrhagia |
2.3% |
Depression |
2.2% |
Vomiting |
2.1% |
Dyspnoea |
2.0% |
Mental Disorder |
2.0% |
General Physical Health Deterioration |
1.9% |
Anhedonia |
1.8% |
Cerebrovascular Accident |
1.8% |
Gallbladder Injury |
1.7% |
Abdominal Pain |
1.6% |
|
Secondary |
Contraception |
23.8% |
Acne |
17.6% |
Premenstrual Syndrome |
13.8% |
Product Used For Unknown Indication |
12.8% |
Menstruation Irregular |
4.0% |
Oral Contraception |
3.6% |
Pain |
3.1% |
Menstrual Cycle Management |
2.8% |
Polycystic Ovaries |
2.7% |
Depression |
2.1% |
Migraine |
2.0% |
Anxiety |
1.8% |
Menorrhagia |
1.7% |
Dysmenorrhoea |
1.5% |
Asthma |
1.3% |
Gastrooesophageal Reflux Disease |
1.3% |
Multiple Allergies |
1.2% |
Headache |
1.1% |
Hypertension |
1.0% |
Hypothyroidism |
0.8% |
|
Pain |
20.6% |
Injury |
16.5% |
Cholecystitis Chronic |
6.9% |
Deep Vein Thrombosis |
6.8% |
Gallbladder Disorder |
6.4% |
Pulmonary Embolism |
6.2% |
Emotional Distress |
5.8% |
Anxiety |
5.7% |
Cholelithiasis |
4.4% |
Gallbladder Injury |
2.6% |
General Physical Health Deterioration |
2.5% |
Anhedonia |
2.4% |
Abdominal Pain Upper |
2.3% |
Abdominal Pain |
2.3% |
Cholecystectomy |
2.2% |
Cholecystitis |
1.6% |
Biliary Dyskinesia |
1.3% |
Cerebrovascular Accident |
1.3% |
Depression |
1.2% |
Thrombosis |
1.2% |
|
Concomitant |
Contraception |
24.1% |
Product Used For Unknown Indication |
9.0% |
Premenstrual Syndrome |
8.7% |
Supplementation Therapy |
8.0% |
Acne |
5.1% |
Depression |
5.1% |
Hormone Level Abnormal |
3.9% |
Gastrooesophageal Reflux Disease |
3.5% |
Multiple Sclerosis |
3.5% |
Diabetes Mellitus |
3.2% |
Asthma |
2.9% |
Crohn's Disease |
2.9% |
Hepatitis C |
2.9% |
Menstrual Cycle Management |
2.9% |
Oral Contraception |
2.9% |
Hiv Infection |
2.6% |
Post Coital Contraception |
2.6% |
Anxiety |
2.3% |
Insomnia |
1.9% |
Pain |
1.9% |
|
Vomiting |
13.6% |
Unintended Pregnancy |
9.1% |
Cholecystitis Chronic |
7.6% |
Menstruation Irregular |
7.6% |
Cholecystitis |
4.5% |
Drug Ineffective |
4.5% |
Dyspnoea |
4.5% |
Gallbladder Disorder |
4.5% |
Hypoaesthesia |
4.5% |
Injury |
4.5% |
Pregnancy |
4.5% |
Pulmonary Embolism |
4.5% |
White Blood Cell Count Increased |
4.5% |
Abdominal Pain |
3.0% |
Abortion Spontaneous |
3.0% |
Anaphylactic Reaction |
3.0% |
Anaphylactic Shock |
3.0% |
Anxiety |
3.0% |
Bone Pain |
3.0% |
Emotional Distress |
3.0% |
|